These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 10951150

  • 1. Treatment of atopic eczema with oral mycophenolate mofetil.
    Neuber K, Schwartz I, Itschert G, Dieck AT.
    Br J Dermatol; 2000 Aug; 143(2):385-91. PubMed ID: 10951150
    [Abstract] [Full Text] [Related]

  • 2. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA, de Bruin-Weller MS.
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
    Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM.
    Arch Dermatol; 2001 Jul; 137(7):870-3. PubMed ID: 11453805
    [Abstract] [Full Text] [Related]

  • 4. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
    Ballester I, Silvestre JF, Pérez-Crespo M, Lucas A.
    Actas Dermosifiliogr; 2009 Dec; 100(10):883-7. PubMed ID: 20038365
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis.
    Murray ML, Cohen JB.
    Clin Exp Dermatol; 2007 Jan; 32(1):23-7. PubMed ID: 17059445
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis.
    Dias-Polak D, Bergman R, Avitan-Hersh E.
    J Dermatolog Treat; 2019 Feb; 30(1):49-51. PubMed ID: 29683760
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
    Talwalkar JA, Angulo P, Keach JC, Petz JL, Jorgensen RA, Lindor KD.
    Am J Gastroenterol; 2005 Feb; 100(2):308-12. PubMed ID: 15667487
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil and skin diseases.
    Hartmann M, Enk A.
    Lupus; 2005 Feb; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients.
    Heller M, Shin HT, Orlow SJ, Schaffer JV.
    Br J Dermatol; 2007 Jul; 157(1):127-32. PubMed ID: 17489974
    [Abstract] [Full Text] [Related]

  • 10. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis.
    Kilmartin DJ, Fletcher ZJ, Almeida JA, Liversidge J, Forrester JV, Dick AD.
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1285-92. PubMed ID: 11328741
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
    Geilen CC, Arnold M, Orfanos CE.
    Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
    [Abstract] [Full Text] [Related]

  • 13. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 14. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM, Somers EC, Fatica RA, McCune WJ.
    J Rheumatol; 2003 Jul; 30(7):1508-12. PubMed ID: 12858449
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T, Peters M, Schlaak JF, Krummenauer F, Wanitschke R, Mayet WJ, Galle PR, Neurath MF.
    Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul 15; 244(7):788-94. PubMed ID: 16163494
    [Abstract] [Full Text] [Related]

  • 18. IgE values and T-lymphocyte subsets in children with atopic eczema/dermatitis syndrome.
    Leonardi S, Rotolo N, Vitaliti G, Spicuzza L, La Rosa M.
    Allergy Asthma Proc; 2007 Jul 15; 28(5):529-34. PubMed ID: 18034970
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK, Liu JX, Li SN, Gao YJ, Lv Y, Xu ZP, Huang BX, Xu SY, Yang DX, Zeng YL, Liu DF, Wang W.
    Int J Mol Sci; 2015 Nov 06; 16(11):26654-66. PubMed ID: 26561804
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review.
    Prussick L, Plotnikova N, Gottlieb A.
    J Drugs Dermatol; 2016 Jun 01; 15(6):715-8. PubMed ID: 27272078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.